Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65313, first published .
Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

Cathy J Reback   1, 2, 3 * , PhD ;   Thomas Blue   1 * , PhD ;   Ali Jalali   4, 5 * , PhD ;   Raphael Landovitz   2, 6 * , MD ;   Michael J Li   2, 3 * , PhD ;   Raymond P Mata   1 * ;   Danielle Ryan   4 * , MPH ;   Philip J Jeng   4 * , MS ;   Sean M Murphy   4, 5 * , PhD

1 Friends Research Institute, Inc., Baltimore, MD, United States

2 Department of Family Medicine, University of California, Center for HIV Identification, Prevention and Treatment Services, Los Angeles, CA, United States

3 Department of Family Medicine, Center for Behavioral and Addiction Medicine, Los Angeles, CA, United States

4 Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States

5 Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV, New York, NY, United States

6 Division of Infectious Diseases, University of California, Los Angeles, CA, United States

*all authors contributed equally

Corresponding Author:

  • Sean M Murphy, PhD
  • Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV
  • 575 Lexington Ave10FL
  • New York
  • New York, NY 10022
  • United States
  • Phone: 1 6469622710
  • Email: smm2010@med.cornell.edu